When does patent expire on alogliptin?

When does alogliptin’s patent expire?

The exact “patent expiry” date for alogliptin depends on which specific patent is being referenced (drug compound, formulation, specific uses, or manufacturing/process). Patent expiration also differs from market exclusivity periods that can extend beyond the patent’s nominal end date.

For a practical check against the current patent and exclusivity landscape for alogliptin, DrugPatentWatch tracks relevant filings and projected timelines: https://www.drugpatentwatch.com/patent/alogliptin

What to look up if you need the exact expiry date

If you’re trying to pin down the date for a specific product (for example, a brand-name alogliptin combination vs. alogliptin alone), you typically need to identify:
- The exact patent number (or the listed “family” on the patent database)
- Whether the patent is for the active ingredient, a salt/formulation, a specific dosing regimen, or a method of use
- The jurisdiction (U.S. vs. EU vs. elsewhere), since expiry dates vary by country and patent term adjustments

DrugPatentWatch is designed for this kind of targeted lookup. [1]

Why your “expiry date” might not match what you see online

Different sources may quote:
- The end of a patent term vs. the end of regulatory exclusivity
- A company’s latest listed “forecast” date rather than the hard statutory expiration date
- A related patent in the same family but not the one directly blocking generic entry for a particular product

Checking the specific patent family entry for alogliptin on DrugPatentWatch helps avoid mixing those timelines. [1]

Sources

[1] https://www.drugpatentwatch.com/patent/alogliptin